Skip to main content
Erschienen in: Langenbeck's Archives of Surgery 8/2018

25.10.2018 | ORIGINAL ARTICLE

Supraclavicular and celiac metastases in squamous cell carcinoma of the middle thoracic esophagus

verfasst von: Akihiko Okamura, Masayuki Watanabe, Ryotaro Kozuki, Tasuku Toihata, Masami Yuda, Yu Imamura, Shinji Mine

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 8/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Squamous cell carcinoma of the middle thoracic esophagus (SCC-ME) often metastasizes to the neck, mediastinum, and abdomen. This study aims to assess the prognostic impact of supraclavicular (SC) and celiac (CE) lymph node (LN) metastases in patients with SCC-ME.

Methods

We examined 210 patients who underwent curative esophagectomy with three-field LN dissection for SCC-ME. The clinicopathological features and survival outcomes of patients with and without SC and/or CE metastases were compared to assess the prognostic significance of SC and/or CE metastases.

Results

We observed metastases to SC and CE in 25 (11.9%) and 20 (9.5%) patients, respectively. Seven patients (3.3%) had both SC and CE metastases. Although the survival of patients with SC and/or CE metastases was worse compared with those without, that of patients with SC metastases but without CE metastases was comparable with that of patients with CE metastases but without SC metastases; the 5 year overall survival rates were 35.6% and 46.2%, respectively. However, survival of patients with both SC and CE metastases was the worst among all groups, and all patients with both SC and CE metastases experienced disease recurrence.

Conclusions

The prognosis of patients with both SC and CE metastases was extremely poor. In contrast, patients with metastasis to either one of these sites could be candidates for surgery as the main modality in a multidisciplinary strategy.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Kuwano H, Nishimura Y, Oyama T, Kato H, Kitagawa Y, Kusano M, Shimada H, Takiuchi H, Toh Y, Doki Y, Naomoto Y, Matsubara H, Miyazaki T, Muto M, Yanagisawa A (2015) Guidelines for diagnosis and treatment of carcinoma of the esophagus april 2012 edited by the Japan esophageal society. Esophagus 12:1–30CrossRef Kuwano H, Nishimura Y, Oyama T, Kato H, Kitagawa Y, Kusano M, Shimada H, Takiuchi H, Toh Y, Doki Y, Naomoto Y, Matsubara H, Miyazaki T, Muto M, Yanagisawa A (2015) Guidelines for diagnosis and treatment of carcinoma of the esophagus april 2012 edited by the Japan esophageal society. Esophagus 12:1–30CrossRef
2.
Zurück zum Zitat Brierley JD, Gospodarowicz MK, Wittekind C (2017) TNM classification of malignant tumors. Wiley, England Brierley JD, Gospodarowicz MK, Wittekind C (2017) TNM classification of malignant tumors. Wiley, England
3.
Zurück zum Zitat Amin MB, Edge SB, Greene FL (2017) AJCC Cancer staging manual. Springer, New YorkCrossRef Amin MB, Edge SB, Greene FL (2017) AJCC Cancer staging manual. Springer, New YorkCrossRef
4.
Zurück zum Zitat Frizzell B, Sinha D, Williams T, Reed CE, Sherman CA, Turrisi A (2003) Influence of celiac axis lymph nodes in the definitive treatment of esophageal cancer. Am J Clin Oncol 26:215–220PubMed Frizzell B, Sinha D, Williams T, Reed CE, Sherman CA, Turrisi A (2003) Influence of celiac axis lymph nodes in the definitive treatment of esophageal cancer. Am J Clin Oncol 26:215–220PubMed
5.
Zurück zum Zitat Seto Y, Fukuda T, Yamada K, Matsubara T, Hiki N, Fukunaga T, Oyama S, Yamaguchi T, Nakajima T, Kato Y (2008) Celiac lymph nodes: distant or regional for thoracic esophageal carcinoma? Dis Esophagus 21:704–707CrossRefPubMed Seto Y, Fukuda T, Yamada K, Matsubara T, Hiki N, Fukunaga T, Oyama S, Yamaguchi T, Nakajima T, Kato Y (2008) Celiac lymph nodes: distant or regional for thoracic esophageal carcinoma? Dis Esophagus 21:704–707CrossRefPubMed
6.
Zurück zum Zitat Chen G, Wang Z, Liu XY, Zhang MY, Liu FY (2009) Abdominal lymph node metastasis in patients with mid thoracic esophageal squamous cell carcinoma. World J Surg 33:278–283CrossRefPubMed Chen G, Wang Z, Liu XY, Zhang MY, Liu FY (2009) Abdominal lymph node metastasis in patients with mid thoracic esophageal squamous cell carcinoma. World J Surg 33:278–283CrossRefPubMed
7.
Zurück zum Zitat Shim YM, Park JS, Lee M, Kim D, Kim K (2013) Can common hepatic artery lymph node dissection be safely omitted in surgery for clinical T1N0 thoracic esophageal squamous cell carcinoma? Dis Esophagus 26:272–275CrossRefPubMed Shim YM, Park JS, Lee M, Kim D, Kim K (2013) Can common hepatic artery lymph node dissection be safely omitted in surgery for clinical T1N0 thoracic esophageal squamous cell carcinoma? Dis Esophagus 26:272–275CrossRefPubMed
8.
Zurück zum Zitat Ma X, Li B, Yang S et al (2014) Extent of lymph node dissection: common hepatic artery lymph node dissection can be omitted for esophageal squamous cell carcinoma. J Thorac Dis 6:S325–S332PubMedPubMedCentral Ma X, Li B, Yang S et al (2014) Extent of lymph node dissection: common hepatic artery lymph node dissection can be omitted for esophageal squamous cell carcinoma. J Thorac Dis 6:S325–S332PubMedPubMedCentral
9.
Zurück zum Zitat Tachimori Y, Ozawa S, Numasaki H, Matsubara H, Shinoda M, Toh Y, Udagawa H, Registration Committee for Esophageal Cancer of the Japan Esophageal Society (2014) Supraclavicular node metastasis from thoracic esophageal carcinoma: a surgical series from a Japanese multi-institutional nationwide registry of esophageal cancer. J Thorac Cardiovasc Surg 148:1224–1229CrossRefPubMed Tachimori Y, Ozawa S, Numasaki H, Matsubara H, Shinoda M, Toh Y, Udagawa H, Registration Committee for Esophageal Cancer of the Japan Esophageal Society (2014) Supraclavicular node metastasis from thoracic esophageal carcinoma: a surgical series from a Japanese multi-institutional nationwide registry of esophageal cancer. J Thorac Cardiovasc Surg 148:1224–1229CrossRefPubMed
10.
Zurück zum Zitat Yamasaki M, Miyata H, Miyazaki Y, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mori M, Doki Y (2014) Evaluation of the nodal status in the 7th edition of the UICC-TNM classification for esophageal squamous cell carcinoma: proposed modifications for improved survival stratification: impact of lymph node metastases on overall survival after esophagectomy. Ann Surg Oncol 21:2850–2856CrossRefPubMed Yamasaki M, Miyata H, Miyazaki Y, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mori M, Doki Y (2014) Evaluation of the nodal status in the 7th edition of the UICC-TNM classification for esophageal squamous cell carcinoma: proposed modifications for improved survival stratification: impact of lymph node metastases on overall survival after esophagectomy. Ann Surg Oncol 21:2850–2856CrossRefPubMed
11.
Zurück zum Zitat Miyata H, Yamasaki M, Miyazaki Y, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mori M, Doki Y (2015) Clinical importance of supraclavicular lymph node metastasis after neoadjuvant chemotherapy for esophageal squamous cell carcinoma. Ann Surg 262:280–285CrossRefPubMed Miyata H, Yamasaki M, Miyazaki Y, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mori M, Doki Y (2015) Clinical importance of supraclavicular lymph node metastasis after neoadjuvant chemotherapy for esophageal squamous cell carcinoma. Ann Surg 262:280–285CrossRefPubMed
12.
Zurück zum Zitat Anderegg MC, Lagarde SM, Jagadesham VP et al (2016) Prognostic significance of the location of lymph node metastases in patients with adenocarcinoma of the distal esophagus or gastroesophageal junction. Ann Surg 264:847–853CrossRefPubMed Anderegg MC, Lagarde SM, Jagadesham VP et al (2016) Prognostic significance of the location of lymph node metastases in patients with adenocarcinoma of the distal esophagus or gastroesophageal junction. Ann Surg 264:847–853CrossRefPubMed
13.
Zurück zum Zitat Cho WK, Oh D, Ahn YC, Shim YM, Zo JI, Sun JM, Ahn MJ, Park K (2017) Supraclavicular and/or celiac lymph node metastases from thoracic esophageal squamous cell carcinoma did not compromise survival following neoadjuvant chemoradiotherapy and surgery. Oncotarget 8:3542–3552PubMed Cho WK, Oh D, Ahn YC, Shim YM, Zo JI, Sun JM, Ahn MJ, Park K (2017) Supraclavicular and/or celiac lymph node metastases from thoracic esophageal squamous cell carcinoma did not compromise survival following neoadjuvant chemoradiotherapy and surgery. Oncotarget 8:3542–3552PubMed
14.
Zurück zum Zitat Honma Y, Hokamura N, Nagashima K, Sudo K, Shoji H, Iwasa S, Takashima A, Kato K, Hamaguchi T, Boku N, Umezawa R, Ito Y, Itami J, Koyanagi K, Igaki H, Tachimori Y (2017) Clinical outcomes of resectable esophageal cancer with supraclavicular lymph node metastases treated with curative intent. Anticancer Res 37:3741–3749PubMed Honma Y, Hokamura N, Nagashima K, Sudo K, Shoji H, Iwasa S, Takashima A, Kato K, Hamaguchi T, Boku N, Umezawa R, Ito Y, Itami J, Koyanagi K, Igaki H, Tachimori Y (2017) Clinical outcomes of resectable esophageal cancer with supraclavicular lymph node metastases treated with curative intent. Anticancer Res 37:3741–3749PubMed
15.
Zurück zum Zitat Rutegard M, Lagergren P, Johar A et al (2017) The prognostic role of coeliac node metastasis after resection for distal oesophageal cancer. Sci Rep 7:43744CrossRefPubMedPubMedCentral Rutegard M, Lagergren P, Johar A et al (2017) The prognostic role of coeliac node metastasis after resection for distal oesophageal cancer. Sci Rep 7:43744CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Sasako M, McCulloch P, Kinoshita T, Maruyama K (1995) New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg 82:346–351CrossRefPubMed Sasako M, McCulloch P, Kinoshita T, Maruyama K (1995) New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg 82:346–351CrossRefPubMed
17.
Zurück zum Zitat Udagawa H, Ueno M, Shinohara H, Haruta S, Kaida S, Nakagawa M, Tsurumaru M (2012) The importance of grouping of lymph node stations and rationale of three-field lymphoadenectomy for thoracic esophageal cancer. J Surg Oncol 106:742–747CrossRefPubMed Udagawa H, Ueno M, Shinohara H, Haruta S, Kaida S, Nakagawa M, Tsurumaru M (2012) The importance of grouping of lymph node stations and rationale of three-field lymphoadenectomy for thoracic esophageal cancer. J Surg Oncol 106:742–747CrossRefPubMed
18.
Zurück zum Zitat Tachimori Y, Ozawa S, Numasaki H et al (2016) Efficacy of lymph node dissection for each station based on esophageal tumor location. Esophagus 13:138–145CrossRef Tachimori Y, Ozawa S, Numasaki H et al (2016) Efficacy of lymph node dissection for each station based on esophageal tumor location. Esophagus 13:138–145CrossRef
19.
Zurück zum Zitat Peters CJ, Hardwick RH, Vowler SL, Fitzgerald RC, on behalf of the Oesophageal Cancer Clinical and Molecular Stratification Study Group (2009) Generation and validation of a revised classification for oesophageal and junctional adenocarcinoma. Br J Surg 96:724–733CrossRefPubMed Peters CJ, Hardwick RH, Vowler SL, Fitzgerald RC, on behalf of the Oesophageal Cancer Clinical and Molecular Stratification Study Group (2009) Generation and validation of a revised classification for oesophageal and junctional adenocarcinoma. Br J Surg 96:724–733CrossRefPubMed
20.
Zurück zum Zitat Fujita H (2015) History of lymphadenectomy for esophageal cancer and the future prospects for esophageal cancer surgery. Surg Today 45:140–149CrossRefPubMed Fujita H (2015) History of lymphadenectomy for esophageal cancer and the future prospects for esophageal cancer surgery. Surg Today 45:140–149CrossRefPubMed
21.
Zurück zum Zitat Ando N, Iizuka T, Ide H, Ishida K, Shinoda M, Nishimaki T, Takiyama W, Watanabe H, Isono K, Aoyama N, Makuuchi H, Tanaka O, Yamana H, Ikeuchi S, Kabuto T, Nagai K, Shimada Y, Kinjo Y, Fukuda H, Japan Clinical Oncology Group (2003) Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan clinical oncology group study–JCOG9204. J Clin Oncol 21:4592–4596CrossRef Ando N, Iizuka T, Ide H, Ishida K, Shinoda M, Nishimaki T, Takiyama W, Watanabe H, Isono K, Aoyama N, Makuuchi H, Tanaka O, Yamana H, Ikeuchi S, Kabuto T, Nagai K, Shimada Y, Kinjo Y, Fukuda H, Japan Clinical Oncology Group (2003) Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan clinical oncology group study–JCOG9204. J Clin Oncol 21:4592–4596CrossRef
22.
Zurück zum Zitat Ando N, Kato H, Igaki H, Shinoda M, Ozawa S, Shimizu H, Nakamura T, Yabusaki H, Aoyama N, Kurita A, Ikeda K, Kanda T, Tsujinaka T, Nakamura K, Fukuda H (2012) A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol 19:68–74CrossRef Ando N, Kato H, Igaki H, Shinoda M, Ozawa S, Shimizu H, Nakamura T, Yabusaki H, Aoyama N, Kurita A, Ikeda K, Kanda T, Tsujinaka T, Nakamura K, Fukuda H (2012) A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol 19:68–74CrossRef
23.
Zurück zum Zitat Foley KG, Christian A, Fielding P, Lewis WG, Roberts SA (2017) Accuracy of contemporary oesophageal cancer lymph node staging with radiological-pathological correlation. Clin Radiol 72:693.e1–693.e7CrossRef Foley KG, Christian A, Fielding P, Lewis WG, Roberts SA (2017) Accuracy of contemporary oesophageal cancer lymph node staging with radiological-pathological correlation. Clin Radiol 72:693.e1–693.e7CrossRef
Metadaten
Titel
Supraclavicular and celiac metastases in squamous cell carcinoma of the middle thoracic esophagus
verfasst von
Akihiko Okamura
Masayuki Watanabe
Ryotaro Kozuki
Tasuku Toihata
Masami Yuda
Yu Imamura
Shinji Mine
Publikationsdatum
25.10.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 8/2018
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-018-1722-x

Weitere Artikel der Ausgabe 8/2018

Langenbeck's Archives of Surgery 8/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.